首页> 美国卫生研究院文献>Cell Death Disease >The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway
【2h】

The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway

机译:S1PR1-STAT3信号通路诱导的骨髓源性抑制细胞产生的转移前生态位促进大肠癌肝转移的机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The tumor-derived factors involved in the expansion and accumulation of myeloid-derived suppressor cells (MDSCs) in metastatic dissemination of colorectal cancer (CRC) to the liver has not been studied. Immunohistochemistry was used to detect sphingosine-1-phosphate receptor 1 (S1PR1) and signal transducer and activator of transcription-3 (STAT3) in human colorectal tumors. IL-6 and interferon-γ were detected by enzyme-linked immunosorbent assay (ELISA). Tumor growth, invasion, and migration were evaluated by MTT, transwell, and wound healing assays, respectively. Subcutaneous tumor-bearing and CRC liver metastasis (CRLM) nude mouse models were constructed. The percentage of MDSCs was measured using multicolor flow cytometry. Western blot assay was used to evaluate S1PR1 and p-STAT3 expression in MDSCs after separation from the liver and tumor by magnetic antibody. T-cell suppression assay was detected by carboxyfluorescein succinimidyl ester (CFSE). Aberrant co-expressed S1PR1 and p-STAT3 was correlated with metachronous liver metastasis and poor prognosis in CRC. A mutual activation loop between S1PR1 and STAT3 can enhance CRC cell proliferation, migration, and invasion in vitro and in vivo. The expression of p-STAT3 and its downstream proteins can be regulated by S1PR1. p-STAT3 was the dependent signaling pathway of S1PR1 in the promotion of cell growth and liver metastasis in CRC. The level of IL-6 and the associated MDSCs stimulated by the S1PR1–STAT3 correlated with the number of liver metastatic nodes in the CRLM mouse models and patients. Increased CD14+HLA-DR−/low MDSCs from CRLM patients inhibited autologous T-cell proliferation and predict poor prognosis. The S1PR1–STAT3–IL-6–MDSCs axis operates in both tumor cells and MDSCs involved in the promotion of growth and liver metastasis in CRC. MDSCs induced by S1PR1–STAT3 in CRC cells formed the premetastatic niche in the liver can promote organ-specific metastasis.
机译:尚未研究在大肠癌(CRC)转移性扩散至肝脏时,髓样来源的抑制细胞(MDSCs)的扩散和积累中涉及的肿瘤衍生因子。免疫组织化学用于检测人大肠肿瘤中的鞘氨醇-1-磷酸受体1(S1PR1)以及信号转导子和转录激活因子3(STAT3)。通过酶联免疫吸附试验(ELISA)检测IL-6和干扰素-γ。分别通过MTT,transwell和伤口愈合测定法评估肿瘤的生长,侵袭和迁移。皮下荷瘤和CRC肝转移(CRLM)裸鼠模型被构建。 MDSCs的百分比是使用多色流式细胞仪测量的。在通过磁性抗体从肝脏和肿瘤分离后,使用蛋白质印迹法评估MDSC中S1PR1和p-STAT3的表达。通过羧基荧光素琥珀酰亚胺酯(CFSE)检测T细胞抑制测定。 S1PR1和p-STAT3共同表达异常与CRC的异时肝转移和预后不良有关。 S1PR1和STAT3之间的相互激活环可以增强CRC细胞的体外,体内增殖,迁移和侵袭。 p-STAT3及其下游蛋白的表达可以由S1PR1调控。 p-STAT3是S1PR1促进CRC细胞生长和肝转移的依赖信号通路。 S1PR1-STAT3刺激的IL-6和相关MDSC的水平与CRLM小鼠模型和患者的肝转移结点数量有关。 CRLM患者CD14 + HLA-DR -//低 MDSCs增加抑制自体T细胞增殖并预后不良。 S1PR1–STAT3–IL-6–MDSCs轴在参与促进CRC生长和肝转移的肿瘤细胞和MDSC中均起作用。 S1PR1-STAT3在CRC细胞中诱导的MDSC在肝脏中形成转移前的生态位,可以促进器官特异性转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号